It’s easy to write off Martin Shkreli and his dramatic price hike of a 62-year-old drug by 5,000% as a one-time deal.
But that’s not the case. Price hikes in the pharmaceutical industry are incredibly common: Earlier this month, Reuters reported that pharma giant Pfizer raised prices on more than 100 of its drugs.
